Stay updated on Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.3.2 was added, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check22 days agoChange DetectedPublications section description updated to indicate publications are automatically filled from PubMed; revision tags updated to v3.3.1 (additions) and v3.2.0 (deletions).SummaryDifference0.0%

- Check30 days agoChange DetectedDeleted the government funding/operating status notice on the page; the study details and endpoints remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedTwo screenshots show the same Study Details page for NCT03989206 with only minor formatting differences. No core content changes to the study, outcomes, or locations were observed.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a new open-label extension study citation for nemolizumab in atopic dermatitis (up to 2 years) with full author list and journal DOI; no deletions observed.SummaryDifference2%

- Check73 days agoChange DetectedUpgrade notice and version bump to v3.2.0; older v3.1.0 removed. Core effect: informs users about possible data/transaction delays due to funding and points to official status pages.SummaryDifference2%

Stay in the know with updates to Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.